Lilly’s New Obesity Awareness Campaign Seeks to Shift Obesity Discourse from Blame to Science and Empathy

▴ Lilly's obesity awareness campaign featuring Varalaxmi Sarathkumar and Nicholai Sachdev
Campaign blends lived experiences with science led perspectives to challenge obesity stigma and emphasise the importance of guidance from doctors.

New Delhi, 26th February 2026: Eli Lilly and Company (India) today announced the next phase of its integrated obesity awareness initiative with a new campaign aimed at reshaping how obesity is perceived and discussed in India. The campaign, led by prominent Indian personalities, blends real-life experiences with science-led perspectives to encourage a shift in conversation from judgment and appearance towards science and empathy, reinforcing the importance of consulting a doctor as part of a comprehensive obesity care pathway. As part of the campaign, three films have been developed: the first featuring Boman Irani and Kayoze Irani; the second with Ratna Pathak Shah and Supriya Pathak; and the third featuring Varalaxmi Sarathkumar.

Obesity in India is often reduced to a question of willpower and lifestyle alone. This campaign challenges that perception by underscoring a science-based reality; as recognized by the World Health Organization (WHO), obesity is a chronic, complex disease influenced by biological, genetic, environmental, and metabolic factors. Drawing on relatable family and social contexts, the campaign reflects the experiences of individuals who frequently face judgment and self-blame, reframing these moments with empathy and scientific understanding. Within the campaign films these prominent personalities highlight the important supportive role friends and family can have in showing empathy, encouragement, and understanding, that can make visiting a doctor feel empowering rather than shameful. At the same time, the campaign affirms obesity as a medical condition, placing doctors at the centre of diagnosis and evidence-based care to encourage informed decision making and foster a more compassionate public narrative.

“Obesity has long been misunderstood in India, frequently framed as a matter of personal choice rather than acknowledged as a complex medical condition,” said Gaurav Mehta, Senior Director, Marketing and Strategic Capabilities, Eli Lilly and Company (India). “Through this next phase of our campaign, we aim to reframe the conversation by combining scientific insight with relatable, real-life narratives that reflect the lived experience of people living with obesity. Our focus is to move the dialogue from blame to understanding, reduce stigma, and empower individuals to seek appropriate, evidence-based care in consultation with qualified doctors who play a central role across the treatment journey.” 

Links to campaign films:

Obesity affects nearly 100 million individuals in India. With an adult obesity prevalence of approximately 6.5 percent in 2023, it is time to shift focus from blame and establish a new paradigm for comprehensive care along with lifestyle modification that people living with obesity deserve.1

To learn more about obesity, visit Obesity Disease & Weight Loss Health Education | Lilly India

The campaign is intended for disease awareness and education purposes only and does not promote any specific product, treatment, or therapy. Individuals are encouraged to consult qualified healthcare professionals for medical advice.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026
Dr. Reddy's Laboratories Launches Nationwide Educational Initiative to Strengthen India's Obesity Care WorkforceSeptember 14, 2026
IIM Bodh Gaya Hosts Convergence 3.0: The Next Frontier of Healthcare SectorSeptember 14, 2026
A Practical Guide to Fibre: How Indian Adults Can Add More Without Digestive DiscomfortSeptember 12, 2026
Understanding Heart Palpitations: Common Triggers, Helpful Records, and Warning SignsSeptember 12, 2026
The Fourth Trimester: Why Healthcare Often Stops Too Early After DeliverySeptember 12, 2026
Postpartum Mental Health: The Healthcare Gap Nobody Talks About EnoughSeptember 12, 2026
Fortis Escorts Faridabad Launches Region’s First Dedicated ‘Fever Clinic’ for Early Diagnosis and Timely TreatmentSeptember 11, 2026